CCRM’s Venture by Design program is built upon our team’s mastery as inventors, scientists,
entrepreneurs and manufacturing experts, spanning the commercialization spectrum for advanced therapies.

Creating disruptive ventures through fearless innovation


Venture by Design is our problem-first company creation stream, aiming to address major unmet clinical needs with disruptive therapy concepts developed through a new innovation model. The concepts are created by our scientist-entrepreneurs, enabled by technology solutions accessed through our established global networks, evaluated by our mentors, and realized as impactful ventures by our company creation experts.


A BOLD, NEW MODEL FOR INNOVATION IN ADVANCED THERAPIES

Screen Opportunity Areas

  • Scope market gaps and unmet clinical needs
  • Utilize our proprietary needs assessment rubric
  • Exploit our flexible model to tailor scope

Ideate on Solutions and Seek Technology Components

  • Ideation on disruptive de novo solutions
  • Access to enabling technologies via 200+ institutions
  • Internal de-risking and feasibility testing, including wet diligence

Proprietary Innovation Model Powered by Custom AI Co-Pilot

  • Deep in-house sector expertise in advanced therapies
  • Artificial intelligence (AI) co-pilot with domain expertise

Resources

  • Seasoned external committee of clinicians, scientists, industry leaders and investors

Read more about the Venture by Design process here.